Skip to content

MultiCell Technologies, Inc.

company.status.inactive

CIK 811779fmd_0R28YJMEH9SXVGRG1Y6S01NXCEManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Dec 01, 2009 to May 31, 2015, 20 periods

Income Statement · Annual · Millions · USD
Line itemFY2010FY2011FY2012FY2013FY2014
Total revenues00000
Research and development––000
Selling, general and administrative11111
Total operating expenses22211
Operating income(2)(2)(2)(1)(1)
Interest expense00000
Interest and investment income00000
Other non-operating income (expense)–––(0)0
Income tax expense–0000
Net income(1)(2)(1)(1)(0)
Net income to common shareholders(1)(2)–––